Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Development of the Cell Population in the Brain White Matter of Young Children.
Liposome-encapsulated peptides protect against experimental allergic encephalitis.
Novel Kv1.3 blockers for immunosuppression: W02012155199.
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation.
Bouncing back again, and again: a qualitative study of resilience in people with multiple sclerosis.
A patient with narcolepsy with cataplexy and multiple sclerosis: two different diseases that may share pathophysiologic mechanisms?
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.
[A different approach to the care of patients with MS].
A simple test of choice stepping reaction time for assessing fall risk in people with multiple sclerosis.
Evaluation of Inner Retinal Layers in Patients with Multiple Sclerosis or Neuromyelitis Optica Using Optical Coherence Tomography.
High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis.
Editorial comment.
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica.
Cognitive impairment and optic nerve axonal loss in patients with clinically isolated syndrome.
Self-management for people with multiple sclerosis: report from the first international consensus conference, november 15, 2010.
The safety risks of innovation: the FDA's Expedited Drug Development Pathway.
Polypharmacy in multiple sclerosis: Relationship with fatigue, perceived cognition, and objective cognitive performance.
Heat sensitive persons with multiple sclerosis are more tolerant to resistance exercise than to endurance exercise.
Acute Disseminated Encephalomyelitis: The Time Until Diagnosis and Its Subsequent Course in Children.
Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate.
Exercise in the community for people with multiple sclerosis -- a follow-up of people with minimal gait impairment.
[Assessment of the risk of the transition of a monofocal clinically isolated syndrome to clinically definite multiple sclerosis.]
Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β
Proteomics comparison of the sera from multiple sclerosis patients and neuromyelitis optica patients.

Pages